Back

Vascular endothelial growth factor-C and cardiovascular and all-cause mortality in patients with chronic kidney disease and suspected coronary artery disease: from the ANOX study

28 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Best Posters 6 - Best Posters in preventive cardiology Biomarkers ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Daisuke Takagi

National Hospital Organization Kyoto Medical Center, Kyouto (Japan)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor M. Maeng (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Professor D. McGuire (Dallas, US)
Abstract Slides
Presentation thumbnail
Doctor B. Zhao (Hobart, AU)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 6 - Best Posters in preventive cardiology

The Event

Event poster

ESC Congress 2018

28 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of chronic kidney disease on the association of vascular endothelial growth factor D with cardiovascular mortality in patients with suspected or known coronary artery disease: the ANOX study
27 August 2023
thumbnail
Congress Presentation
C-X-C motif chemokine ligand 5 (CXCL5) is associated with risk of all-cause mortality in a U-shaped manner in patients admitted with chest pain of suspected coronary origin.
1 September 2025
thumbnail
Congress Presentation
Vascular endothelial growth factor c serum level at admission and discharge provides different prognostic values in acute heart failure.
21 May 2023
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources